Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: diaDexus, Inc.

Market Cap 49.2T 43.22T 39.83T 37.28T 69.85T 46.61L 71.03T 5L 2L 22.87L 2L 2L 79.48L P/E 2014
-3.26x
P/E 2015 -1.14x
Enterprise Value 52.9L 46.47L 42.82L 40.09L 75.11L 50Cr 76.37L 5.14Cr 1.99Cr 25Cr 1.99Cr 1.94Cr 85Cr EV / Sales 2014
1.05x
EV / Sales 2015 0.77x
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%+16.10%-21.67%-42.53% 285.04Cr
-1.02%+10.99%-7.18%-84.65% 186.34Cr
-4.68%-11.71%-15.38%-4.27% 30Cr
-5.05%-13.31%-45.02% - 5.56Cr
Average -2.81%+2.47%-22.31%-43.81% 126.79Cr
Weighted average by Cap. -0.97%+13.66%-16.23%-55.87%

Financials

2014 2015
Net sales 2.61Cr 2.29Cr 2.11Cr 1.98Cr 3.71Cr 247.36Cr 3.77Cr 25Cr 9.82Cr 121.37Cr 9.8Cr 9.59Cr 421.82Cr 1.79Cr 1.57Cr 1.45Cr 1.36Cr 2.54Cr 169.41Cr 2.58Cr 17Cr 6.73Cr 83Cr 6.71Cr 6.57Cr 288.9Cr
Net income -84.67L -74.38L -68.54L -64.16L -1.2Cr -80Cr -1.22Cr -8.23Cr -3.19Cr -39Cr -3.18Cr -3.11Cr -136.78Cr -71.66L -62.95L -58.01L -54.3L -1.02Cr -68Cr -1.03Cr -6.97Cr -2.7Cr -33Cr -2.69Cr -2.63Cr -115.76Cr
Net Debt -2L -2L -2L -2L -3L -1.88Cr -3L -19.25L -7L -92.03L -7L -7L -3.2Cr 52.41L 46.04L 42.43L 39.72L 74.41L 50Cr 75.66L 5.09Cr 1.97Cr 24Cr 1.97Cr 1.93Cr 85Cr
Logo diaDexus, Inc.
Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!